SK557685A3 - Alpha-aryl-4-/4,5-dihydro-3,5-dioxo-1,2,4-triazine- -2(3h)yl/benzeneacetonitriles and manufacturing process thereof - Google Patents

Alpha-aryl-4-/4,5-dihydro-3,5-dioxo-1,2,4-triazine- -2(3h)yl/benzeneacetonitriles and manufacturing process thereof Download PDF

Info

Publication number
SK557685A3
SK557685A3 SK5576-85A SK557685A SK557685A3 SK 557685 A3 SK557685 A3 SK 557685A3 SK 557685 A SK557685 A SK 557685A SK 557685 A3 SK557685 A3 SK 557685A3
Authority
SK
Slovakia
Prior art keywords
chloro
dioxo
chlorophenyl
triazine
phenyl
Prior art date
Application number
SK5576-85A
Other languages
English (en)
Slovak (sk)
Other versions
SK278310B6 (en
Inventor
Gustaaf M Boeckx
Alfons H M Raeymaekers
Victor Sipido
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SK557685A3 publication Critical patent/SK557685A3/sk
Publication of SK278310B6 publication Critical patent/SK278310B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Lubricants (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SK5576-85A 1984-08-01 1985-07-30 Alpha-aryl-4-/4,5-dihydro-3,5-dioxo-1,2,4-triazine- -2(3h)yl/benzeneacetonitriles and manufacturing process thereof SK278310B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63653884A 1984-08-01 1984-08-01

Publications (2)

Publication Number Publication Date
SK557685A3 true SK557685A3 (en) 1996-09-04
SK278310B6 SK278310B6 (en) 1996-09-04

Family

ID=24552347

Family Applications (1)

Application Number Title Priority Date Filing Date
SK5576-85A SK278310B6 (en) 1984-08-01 1985-07-30 Alpha-aryl-4-/4,5-dihydro-3,5-dioxo-1,2,4-triazine- -2(3h)yl/benzeneacetonitriles and manufacturing process thereof

Country Status (36)

Country Link
EP (1) EP0170316B1 (es)
JP (2) JPS6143176A (es)
KR (1) KR870000787B1 (es)
CN (1) CN1016687B (es)
AT (1) ATE53206T1 (es)
AU (1) AU579653B2 (es)
BG (1) BG46599A3 (es)
CA (2) CA1244024A (es)
CY (1) CY1656A (es)
CZ (1) CZ277962B6 (es)
DE (1) DE3577984D1 (es)
DK (1) DK166414B1 (es)
DZ (1) DZ814A1 (es)
EG (1) EG17589A (es)
ES (2) ES8609284A1 (es)
FI (1) FI90235C (es)
GR (1) GR851837B (es)
HK (1) HK68092A (es)
HU (1) HU194191B (es)
IE (1) IE58076B1 (es)
IL (1) IL75962A (es)
LT (1) LT2069B (es)
LV (2) LV5027A3 (es)
MA (1) MA20497A1 (es)
NO (1) NO171634C (es)
NZ (1) NZ212770A (es)
PH (1) PH21137A (es)
PL (1) PL147667B1 (es)
PT (1) PT80903B (es)
RO (1) RO92300B (es)
SG (1) SG65992G (es)
SK (1) SK278310B6 (es)
SU (1) SU1443799A3 (es)
ZA (1) ZA855793B (es)
ZM (1) ZM5385A1 (es)
ZW (1) ZW12385A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0185731A4 (en) * 1984-06-12 1988-11-02 Fmc Corp WEED-KILLING 2-ARYL-1,2,4-TRIAZINE-3,5 (2H, 4H) -DIONE AND THEIR SULFUR ANALOGS.
DE3531919A1 (de) * 1985-09-07 1987-03-19 Hoechst Ag Substituierte 2-phenyl-hexahydro-1,2,4-triazin-3,5-dione, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
DE3826058A1 (de) * 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
EP0364765A3 (de) * 1988-10-08 1991-07-17 Bayer Ag Substituierte 1,3,5-Triazintrione, Verfahren zu ihrer Herstellung und ihre Verwendung gegen parasitäre Protozoen
EP0377903A3 (de) * 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
ES2058463T3 (es) * 1989-01-09 1994-11-01 Bayer Ag Agentes contra protozoos en insectos.
CN1044905A (zh) * 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
DE4030042A1 (de) * 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
EP0476439A1 (de) * 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
US5830893A (en) * 1997-04-23 1998-11-03 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones
US6867207B2 (en) 1997-07-10 2005-03-15 Janssen Pharmaceutica N.V. IL-5 inhibiting 6-azauracil derivatives
WO1999002505A1 (en) * 1997-07-10 1999-01-21 Janssen Pharmaceutica N.V. Il-5 inhibiting 6-azauracil derivatives
EP0987265A1 (en) 1998-09-18 2000-03-22 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
IL143766A (en) 1998-12-18 2005-11-20 Janssen Pharmaceutica Nv Il-5 inhibiting 6-azauracil derivatives
WO2001010866A1 (en) 1999-08-06 2001-02-15 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
CN101265238B (zh) * 2007-12-12 2010-06-16 重庆天极旅业有限公司 一种三嗪环衍生物的合成方法
CN101265216B (zh) * 2007-12-18 2012-06-27 重庆华邦胜凯制药有限公司 4-(取代乙氰基)-苯腙衍生物及其合成方法
CN102911080B (zh) * 2012-09-12 2015-01-21 衢州学院 一种制备2,6-二氯-α-(4-氯苯基)-4-硝基苯乙腈的方法
CN107746390B (zh) * 2017-11-21 2021-03-16 连云港市亚晖医药化工有限公司 抗球虫药地克珠利的制备方法
CN113999139A (zh) * 2021-12-03 2022-02-01 杭州臻峰科技有限公司 制备2，6-二氯-α-（4-氯代苯基） -4-硝基苯乙腈的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912723A (en) * 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
US3905971A (en) * 1971-03-29 1975-09-16 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
GB1448696A (en) * 1973-05-29 1976-09-08 Pfizer 2-phqnyl-astriazine-3,4-2h,4h-diones

Also Published As

Publication number Publication date
CN85105673A (zh) 1987-01-14
RO92300A (ro) 1987-11-30
PL254700A1 (en) 1986-09-23
SK278310B6 (en) 1996-09-04
FI852958A0 (fi) 1985-07-31
ES8609284A1 (es) 1986-07-16
FI90235B (fi) 1993-09-30
EP0170316B1 (en) 1990-05-30
PH21137A (en) 1987-07-27
JPH0625177B2 (ja) 1994-04-06
SU1443799A3 (ru) 1988-12-07
ATE53206T1 (de) 1990-06-15
ZW12385A1 (en) 1987-02-25
KR860001796A (ko) 1986-03-22
ES552443A0 (es) 1987-05-01
CY1656A (en) 1993-05-14
NO853037L (no) 1986-02-03
DE3577984D1 (de) 1990-07-05
KR870000787B1 (ko) 1987-04-18
MA20497A1 (fr) 1986-04-01
HU194191B (en) 1988-01-28
HK68092A (en) 1992-09-18
CN1016687B (zh) 1992-05-20
CZ277962B6 (en) 1993-07-14
RO92300B (ro) 1987-12-02
BG46599A3 (en) 1990-01-15
IL75962A (en) 1989-09-28
HUT39433A (en) 1986-09-29
SG65992G (en) 1992-09-04
LV5772B4 (lv) 1997-06-20
PT80903A (en) 1985-09-01
FI852958L (fi) 1986-02-02
CA1244024A (en) 1988-11-01
EP0170316A3 (en) 1986-11-05
NO171634C (no) 1993-04-14
NZ212770A (en) 1988-10-28
JPS6143176A (ja) 1986-03-01
PL147667B1 (en) 1989-07-31
LV5027A3 (lv) 1993-06-10
ZM5385A1 (en) 1987-03-27
EP0170316A2 (en) 1986-02-05
LV5772A4 (lv) 1996-12-20
NO171634B (no) 1993-01-04
JPH0420435B2 (es) 1992-04-02
AU4566485A (en) 1986-02-06
AU579653B2 (en) 1988-12-01
ZA855793B (en) 1987-03-25
EG17589A (en) 1991-12-30
DK347585D0 (da) 1985-07-31
PT80903B (pt) 1987-11-11
JPH0517454A (ja) 1993-01-26
LT2069B (lt) 1993-06-15
DZ814A1 (en) 2004-09-13
IE58076B1 (en) 1993-06-30
DK347585A (da) 1986-02-02
ES8705403A1 (es) 1987-05-01
CA1305479C (en) 1992-07-21
CZ557685A3 (en) 1993-02-17
FI90235C (fi) 1994-01-10
GR851837B (es) 1985-12-02
IE851911L (en) 1986-02-01
IL75962A0 (en) 1985-12-31
ES545744A0 (es) 1986-07-16
DK166414B1 (da) 1993-05-17

Similar Documents

Publication Publication Date Title
SK557685A3 (en) Alpha-aryl-4-/4,5-dihydro-3,5-dioxo-1,2,4-triazine- -2(3h)yl/benzeneacetonitriles and manufacturing process thereof
FI94634C (fi) Analogiamenetelmä alkueläintenvastaisesti vaikuttavien 5,6-dihydro-2-(substituoitu fenyyli)-1,2,4-triatsiini-3,5(2H,4H)-dionijohdannaisten valmistamiseksi
DK175781B1 (da) Pyrimidinforbindelse med CNS-aktivitet, fremgangsmåder til dens fremstilling og farmaceutiske præparater indeholdende den
RU2091374C1 (ru) Способ получения замещенных 5-арил-пиримидинов
US4631278A (en) Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
JPH0237353B2 (es)
RU2269519C2 (ru) Соединения фенилпиридазина и содержащие их лекарственные средства
JPH0143747B2 (es)
US3905971A (en) 2-Phenyl-as-triazine-3,5(2H,4H)diones
HU191566B (en) Process for preparing 5-amino-6-/substituted phenyl/-2,3-dihydro-3-imino-2-alkyl-1,2,4-triazine derivatives and pharmaceutical compositions containing such compunds as active substances
Asif et al. Antitubercular and Anticonvulsant Activities of Phenyl-di-hydropyridazinone Derivatives Containing 2-Substituted amin-1-yl-methyl and 2-(2-1H-amin-1-yl) ethyl Moieties
SK1652004A3 (sk) Použitie inhibítorov fosfodiesterázy IV
NL8104766A (nl) Pyrimidine-derivaten.
JP4546082B2 (ja) 心臓疾患及びアレルギーの治療のためのｐｄｅｉｖ阻害作用及びｔｎｆ拮抗作用を有する４−（ベンジリデンアミノ）−３−（メチルスルファニル）−４ｈ−１，２，４−トリアジン−５−オン誘導体
US4778887A (en) α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitriles
US4629729A (en) Endowed with anti-viral activity 2-alkylamino-4,6-dihalo pyrimidines
CZ2004528A3 (cs) Substituované deriváty alkylaminopyridazinonuŹ způsob jejich přípravy a farmaceutická kompozice je obsahující
SK180999A3 (en) 6-azauracil derivatives as il-5 inhibitors, process for preparing and pharmaceutical compositions
SI9010607A (en) Pharmacologically active cns compounds
CZ689889A3 (cs) Pyrimidinové deriváty, způsob jejich výroby a farmaceutický prostředek s jejich obsahem
JPH0688982B2 (ja) 新規ピリミジンジオン誘導体及び該化合物を含有する抗不整脈剤